📊 Analyst Consensus & Targets
- Analyst Rating: Buy
- Price Target: $428.11334
- Sector: Healthcare – Medical Devices
💡 The Growth Thesis
Buy Consensus: Stryker Corporation operates as a medical technology company. Analysts project a 21.8% potential upside. Currently trading at a Forward P/E of 23.52112.